PD-0417 Planned total duration of triptorelin treatment in patients with prostate cancer, TALISMAN study. (May 2022) - Crehange, G.; Lebret, T.; Rigaud, J.; Pello-Leprince-Ringuet, N.; Grandoulier, A.S.; Thiery Vuillemin, A.